Skip to main content
SpringerLink
Log in

The Evolution of Performance-Enhancing Drug Use in Sport

  • Chapter
  • First Online:
Emerging Drugs in Sport

Abstract

This chapter traces the emergence of the major classes of performance-enhancing drugs (PEDs) used in sport such as stimulants and steroids and also techniques that have potential to enhance performance such as gene doping. Trends in use of PEDs are examined along with progress in adapting anti-doping regulations and developing methods to identify PEDs. The chapter also examines the relationship between PED consumption in elite sport and use by non-elite athletes, especially young athletes, and gym users.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Prokop L (1970) The struggle against doping and its history. J Sports Med Phys Fitness 10:45

    CAS  PubMed  Google Scholar 

  2. Müller RK (2010) History of doping and doping control. In: Thieme D, Hammersbach P (eds) Doping in sports: handbook of experimental pharmacology 195. Springer-Verlag, Berlin, pp 1–23

    Google Scholar 

  3. Dimeo P (2007) A history of drug use in sport 1876–1976: beyond good and evil. Routledge, London

    Google Scholar 

  4. Malcolm D, Smith A (2015) Drug use in professional football. In: Møller V, Waddington I, Hoberman JH (eds) Routledge handbook of drugs and sport. Routledge, London, pp 103–114

    Chapter  Google Scholar 

  5. Koh B (2015) Drug use in swimming. In: Møller V, Waddington I, Hoberman JH (eds) Routledge handbook of drugs and sport. Routledge, London, pp 128–144

    Chapter  Google Scholar 

  6. Novak (1964) In Dimeo P (2007) a history of drug use in sport 1876–1976: beyond good and evil. Routledge, London, p 272

    Google Scholar 

  7. Dejonghe T (2007) Sport in de wereld. Academia Press, Gent, Belgium

    Google Scholar 

  8. Statista (2020) Sport events worldwide. Available at: https://www.statista.com/outlook/272/100/sport-events/worldwide Accessed 19 Oct 2020

  9. Houlihan B, Zheng J (2013) The Olympics and elite sport policy: where will it all end? Int J Hist Sport 30:338–355

    Article  Google Scholar 

  10. Mazzoni I, Barroso O, Rabin O (2011) The list of prohibited substances and methods in sport: structure and review process by the World Anti-Doping Agency. J Anal Toxicol 35:608–612

    Article  CAS  Google Scholar 

  11. WADA (2019) 2018 anti-doping testing figures. Montreal, WADA

    Google Scholar 

  12. Aguilar-Navarro M, Salinero JJ, Muñoz-Guerra J, del Mar PM, del Coso J (2020) Sport-specific use of doping substances: analysis of World Anti-Doping Agency doping control tests between 2014 and 2017. Subst Use Misuse 55:1361–1369

    Article  Google Scholar 

  13. Goldman B, Klatz R (1992) Death in the locker room. Elite Sports Medicine Publications, Chicago, p 47

    Google Scholar 

  14. Voy RO (1991) Drugs, sport, and politics, vol. 10. Human Kinetics Publishers, Champaign, IL

    Google Scholar 

  15. Hunt TM (2007). Drug games: The international politics of doping and the Olympic Movement, 1960–2007. Doctoral dissertation. University of Texas at Austin, p 6

    Google Scholar 

  16. Government of Australia (1989) Drugs in sport, interim report of the senate standing committee on the environment, recreation and the arts. Australian Government Publishing Service, Canberra

    Google Scholar 

  17. WADA (2011) 2010 Adverse analytical findings and atypical findings reported by accredited laboratories. Montreal, WADA

    Google Scholar 

  18. Dandoy and Gereige (2012) Performance and enhancing drugs. Pediatr Rev 33(6):265–272

    Article  Google Scholar 

  19. NIDA. Who uses steroids. Available at: https://www.drugabuse.gov/publications/research-reports/steroids-other-appearance-performance-enhancing-drugs-apeds/who-uses-anabolic-steroids Accessed 10 Sept 2020

  20. Nilsson S, Baigi A, Marklund B, Fridlund B (2001) The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. Eur J Public Health 11:195–197

    Article  CAS  Google Scholar 

  21. Sas-Nowosielski K (2006) The abuse of anabolic-androgenic steroids by polish school-aged adolescents. Biol Sport 23:225–232

    Google Scholar 

  22. Grace F, Baker J, Davies B (2001) Anabolic androgenic steroid use in recreational gym users: a regional sample of the mid-Glamorgan area. J Subst Abus 6:189–195

    Google Scholar 

  23. Kokkevi A, Fotiou A, Chileva A, Nociar A, Miller P (2008) Daily exercise and anabolic steroids use in adolescents: a cross-national European study. Subst Use Misuse 43:2053–2065

    Article  Google Scholar 

  24. Stubbe JH, Chorus AM, Frank LE, de Hon O, van der Heijden PG (2014) Prevalence of use of performance enhancing drugs by fitness Centre members. Drug Test Anal 6:434–438

    CAS  PubMed  Google Scholar 

  25. McVeigh J, Begley E (2017) Anabolic steroids in the UK: an increasing issue for public health. Drugs Edu Prev Policy 24:278–285

    Article  Google Scholar 

  26. Christiansen AV (2015) Drug use in gyms. In: Møller V, Waddington I, Hoberman JH (eds) Routledge handbook of drugs and sport. Routledge, London, p 424

    Google Scholar 

  27. Sonksen PH, Cowan D, Holt R (2016) Use and misuse of hormones in sport. Lancet Diabetes Endocrinol 4:882–883

    Article  Google Scholar 

  28. Inquiry D (1990) Commission of Inquiry into the use of drugs and banned practices intended to increase athletic performance, commissioner, C.L. Canadian Government Printing Centre, Dubin, Ottawa, p 120

    Google Scholar 

  29. Cadwallader AB, De La Torre X, Tieri A, Botrè F (2010) The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis. Br J Pharmacol 161(1–16):882–883

    Google Scholar 

  30. Sánchez-Oliver AJ, Grimaldi-Puyana M, Domínguez R (2019) Evaluation and behavior of Spanish bodybuilders: doping and sports supplements. Biomol Ther 9:122

    Google Scholar 

  31. Tavares ASR, Serpa S, Horta L, Carolino E, Rosado A (2020) Prevalence of performance-enhancing substance use and associated factors among Portuguese gym/fitness users. Subst Use Misuse 55:1059–1067

    Article  Google Scholar 

  32. Lopez S et al (2020) Gene doping and genomic science in sports: where are we? Bioanalysis 12(11):801–811

    Article  CAS  Google Scholar 

  33. Schifano F (2018) Recent changes in drug abuse scenarios: the new/novel psychoactive substances (NPS) phenomenon. Brain Sci 8:1–3

    Google Scholar 

  34. Mazzoni I, Barroso O, Rabin O (2017) Anti-doping challenges with novel psychoactive substances in sport. In: Corazza O, Roman-Urrestarazu A (eds) Novel psychoactive substances. Springer, Berlin, pp 43–56

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Loughborough University, Loughborough, UK

    Barrie Houlihan

Authors
  1. Barrie Houlihan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barrie Houlihan .

Editor information

Editors and Affiliations

  1. Science and Medicine Department, World Anti-Doping Agency (WADA), Montreal, QC, Canada

    Olivier Rabin

  2. Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK

    Ornella Corazza

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Houlihan, B. (2022). The Evolution of Performance-Enhancing Drug Use in Sport. In: Rabin, O., Corazza, O. (eds) Emerging Drugs in Sport. Springer, Cham. https://doi.org/10.1007/978-3-030-79293-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-79293-0_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-79292-3

  • Online ISBN: 978-3-030-79293-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation